SNOASonoma Pharmaceuticals, Inc.

Nasdaq sonomapharma.com


$ 0.18 $ -0.01 (-5.11 %)    

Wednesday, 26-Jun-2024 15:44:11 EDT
QQQ $ 478.80 $ 0.99 (0.21 %)
DIA $ 391.21 $ 0.22 (0.06 %)
SPY $ 545.04 $ 0.68 (0.12 %)
TLT $ 93.14 $ -1.35 (-1.43 %)
GLD $ 212.60 $ -1.98 (-0.92 %)
$ 0.1802
$ 0.19
$ 0.00 x 0
$ 0.00 x 0
$ 0.18 - $ 0.19
$ 0.12 - $ 1.19
1,172,039
na
3.38M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-17-2024 03-31-2024 10-K
2 02-08-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 06-21-2023 03-31-2023 10-K
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 07-13-2022 03-31-2022 10-K
10 02-11-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 07-14-2021 03-31-2021 10-K
14 02-16-2021 12-31-2020 10-Q
15 11-20-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 07-10-2020 03-31-2020 10-K
18 02-14-2020 12-31-2019 10-Q
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 07-01-2019 03-31-2019 10-K
22 02-14-2019 12-31-2018 10-Q
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 06-26-2018 03-31-2018 10-K
26 02-14-2018 12-31-2017 10-Q
27 11-14-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 06-28-2017 03-31-2017 10-K
30 02-17-2017 12-31-2016 10-Q
31 11-15-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 06-21-2016 03-31-2016 10-K
34 02-16-2016 12-31-2015 10-Q
35 11-10-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 06-16-2015 03-31-2015 10-K
38 02-12-2015 12-31-2014 10-Q
39 11-13-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonoma-pharmaceuticals-q4-eps-007-up-from-031-yoy-sales-344m-miss-398m-estimate

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over loss...

 sonoma-pharmaceuticals-announced-the-expansion-of-its-microcyn-negative-pressure-wound-therapy-npwt-solution-products-in-the-us

Microcyn Negative-Pressure Wound Therapy Solution, an innovation in advanced wound care, is now available in convenient sizes o...

 sonoma-pharmaceuticals-highlights-safety-advantages-of-microcyn-products

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology b...